May 16 2023 release
New pharmacotherapy terms added
MAxO ID | MAxO label |
---|---|
MAXO:0001469 | farnesyltransferase inhibitor agent therapy |
MAXO:0001470 | MMP inhibitor agent therapy |
MAXO:0001474 | thyroid hormone therapy |
MAXO:0001475 | sodium-glucose cotransporter-2 inhibitor therapy |
MAXO:0001476 | somatostatin recepter agonist therapy |
MAXO:0001473 | benzothiadiazine derivative therapy |
MAXO:0001471 | tazarotene agent therapy |